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Abstract

By Christopher Naranjo
University of the Pacific
2019

The methylotrophic yeast Pichia pastoris has been utilized for heterologous protein
expression for research, clinical, and industrial purposes to produce thousands of recombinant
protein products. Because P. pastoris secretes very few of its own proteins, the exported
recombinant protein is the major polypeptide in the extracellular medium, making purification
relatively easy. Unfortunately, a disadvantage to the programmed export is that some
recombinant proteins intended for secretion are retained within the cell and may be subsequently
degraded. A mutant strain isolated in our lab, containing a pREMI-derived disruption of the
BGS13 gene, has displayed elevated levels of secretion for a variety of reporter proteins. The
wild-type protein expressed from this gene shares homology with the S. cerevisiae Pkc1 protein.
It has been elucidated that the Bgs13 protein plays a crucial role in the P. pastoris secretory
network, but its specific mode(s) of action is currently unclear.
To reveal the differences in the secretion mechanism and cell wall integrity between
wild-type P. pastoris and the bgs13 strain, we identified and characterized differential protein
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populations found in the extracellular medium and those extracted from the cell wall. The
proteomic approach revealed that the bgs13 strain released an increased array of normally
secreted proteins, endogenous proteins, and Endoplasmic Reticulum(ER)-resident chaperones.
The role of the Bgs13 protein in the Cell Wall Integrity pathway was further investigated by an
analysis of the relative cell wall porosity that indicated comparable porosity between the wildtype and bgs13 strains. Because ER-resident chaperones were found to be released in higher
abundance by the bgs13 strain, intracellular protein disulfide isomerase levels were analyzed, but
no major differences between the two strains were detected. Nonetheless, this result points to a
possible occurrence of an unorthodox mode of protein sorting in the bgs13 strain that leads to
enhanced release of proteins and cell wall structural changes. This research explicated, in part,
the underlying mechanisms of enhanced secretion of the bgs13 strain.
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Chapter 1: Introduction
Heterologous Protein Expression
It is often viewed that the molecular workhorses of the cell are proteins, which are
polymer chains made up of 20 possible amino acids arranged in different orders and lengths.
Proteins have a wide range of functions in the biological realm. Some compose the architecture
of the cell’s structure and others can even come together to form a tubular protein complex that
is capable of degrading other proteins to pieces as they pass through.
Differences in the primary amino acid sequence gives rise to unique proteins. The
primary sequence of a protein’s amino acid chain is the major determining factor of how the
amino acid chain that composes the protein will fold in three-dimensional space. The primary
amino acid sequence of a protein is determined by the nucleotide sequence of its respective gene,
which follows the genetic code (Crick et al., 1961). The gene’s corresponding DNA sequence is
then transcribed into mRNA that will then be used as a template for protein synthesis via the
ribosome in a process known as ‘translation’ (Bossi and Roth, 1980). Protein expression refers
to the synthesis, modification, and regulation of proteins in biological systems. Major functions
of proteins in cells include, but are most certainly not limited to, roles in metabolism, cellular
structure and support, and regulation of gene transcription. Like the other macromolecules,
proteins play essential roles in all domains of life by participating in all compartments and
functions of a cell. To elucidate the roles and effects of proteins in biological processes, they
must be systematically expressed and purified. Biological research of proteins encompasses both
the study of the protein itself as well as the experimental techniques used for successful protein
expression.
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In order to produce a particular protein of interest, living cells and their natural cellular
translational machinery must be utilized for this controlled expression. These cells can be
considered to operate as “factories” that will initiate expression of protein that is derived from a
known, given DNA sequence that encodes a gene - typically distinctive from what is naturally
found in the specific host cell type. Species or cell types used for this form of protein expression
are often referred to as expression systems.
Due to the relative ease of DNA synthesis and design, it is an essential tool for much of
protein-based biological research: DNA templates can be incorporated and used by biologically
active cells to heterologously express ‘recombinant’ protein. Recombinant protein expression is
not only used to study proteins but has become one of the most prominent methods of
synthesizing large-scale quantities of heterologous protein. The increased scale of production is
typically prepared for commercial, clinical, and research purposes. Over the past few decades,
heterologous protein expression has become one of the primary means to produce therapeutic
and pharmaceutical proteins (Chen, 2012; Wurm, 2004; Gecchele et al., 2015; De Schutter et al.,
2009).
The origin of the host cell type being used, or of the protein being studied, is a crucial
factor in forming the recombinant protein expression system that will be used. Because
prokaryotic and eukaryotic cells have vastly different cellular compositions and biological
mechanisms (Kozak, 1999), they will give rise to different expression systems to be utilized for
recombinant protein expression. Escherichia coli, with its extensively characterized genetics, is
a widely used host organism for prokaryotic recombinant expression (Baneyx, 1999; Baneyx and
Mujacic, 2004). Regarding eukaryotic heterologous protein expression, there is an array of host
organisms than can be utilized.
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Mammalian cells have proved useful in generating correctly folded, functional
therapeutic proteins for treatment in humans due to their native cellular machinery. However,
their innate complexity leads to challenges that must be overcome during recombinant protein
cultivation from mammalian cells (Wurm, 2004). A relatively simple single-celled eukaryote
that is widely used for heterologous protein production is the budding yeast (Cherry et al., 2012).
The yeast’s compartmentalized eukaryotic organelles allow a multitude of advantages over
simpler prokaryotic systems including, but not limited to, post-translational modifications,
polypeptide folding mechanisms, and regulation of proteins to achieve native biological activity.
This includes disulfide bond formation, N-linked and O-linked glycosylation of amino acid
residue (Lin-Cereghino and Cregg, 2000), and proteolytic maturation of proteins. Their
unicellular nature allows for relatively rapid growth and genetic manipulation that is needed to
optimally take advantage of the budding yeasts as a recombinant expression systems. Their
ability to secrete proteins can also be considered as a valuable initial step of purification, which
eliminates the need to account for cell lysis and any subsequent impurities that arise. Although
Saccharomyces cerevisiae is the most used and characterized species of budding yeast, it carries
certain disadvantages regarding its use as a recombinant expression system (Buckholz and
Gleeson, 1991). Our focus is on an ascomycetous yeast that is at the forefront of eukaryotic
recombinant protein expression: Pichia pastoris.
Pichia pastoris: A Recombinant Expression System
Since the 20th century, yeasts have been characterized and used for the purpose of
recombinant protein expression. In the late 1960s, it was first described that certain yeasts had
the capability to sufficiently grow on medium that utilized methanol as the only carbon source
(Ogata et al., 1969). While P. pastoris was a species originally utilized to produce single-cell
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protein animal feed, this application showcased the methylotrophic single-celled eukaryote’s
potential as a recombinant host organism. The foundation of P. pastoris as a recombinant
protein expression lies upon some uniquely activated enzymes that are expressed in the methanol
utilization pathway (Cregg et al., 1987; Lin-Cereghino and Cregg, 2000). When grown on
methanol-containing medium, alcohol oxidase (AOX) is the first enzyme to encounter methanol
in the peroxisome, catabolizing it into formaldehyde and hydrogen peroxide. From there onward
lies more enzymatic activity that is part of the utilization pathway, including assimilation of
formaldehyde to produce cellular constituents and energy for the cells growing on methanol
(Lin-Cereghino and Cregg, 2000). Alcohol oxidase is present at large quantities when
expression is induced on methanol but has undetectable levels when grown on other carbon
sources. When expressed, it can account for up to 35% of the total protein produced in the P.
pastoris cell (Sreekrishna et al., 1997). AOX1 and AOX2 are two genes that encode the AOX
enzyme, but AOX1 has been shown to be the primary gene that facilitates methanol oxidation
(Cregg et al., 1989). Expression of the AOX1 gene is transcriptionally regulated; its promoter
element is repressed/derepressed by other carbon sources such as glycerol or glucose, and the
presence of methanol induces AOX1 derepression and expression (Tschopp et al., 1987).
The genetic techniques required to convert P. pastoris into an expression system include
traditional standard molecular biology techniques such as DNA-mediated cloning and
transformation via electroporation. Homologous recombination between genomic DNA and
artificially introduced DNA is also utilized by P. pastoris; a form of homologous recombination
arises when cleavage of an introduced DNA vector produces a sequence shared with the host
genome that leads to integration of the vector into the genomic locus (Lin-Cereghino and Cregg,
2000). When compared to the introduction of centromeric vectors, integration into the genome
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increases the stability of expression strains. The typical workflow of heterologous expression is
composed of the following: Insertion of the foreign gene of interest into an expression vector,
introduction of the vector into P. pastoris, screening for potential expression strains,
selection/isolation of the strain(s) of interest, large-scale expression of the gene product, and
final purification of the recombinant protein. Most P. pastoris strains that are used for
recombinant expression are selected for successful transformation with vectors that contain an
appropriate selectable marker (Lin-Cereghino and Cregg, 2000). Vectors used for foreign gene
expression are usually E. coli/P. pastoris shuttle vectors. They contain an expression cassette
composed of the 5’ AOX1 promoter sequences and a second AOX1 fragment needed for
transcriptional termination (Cregg et al., 1989). A multiple cloning site for the introduction of
the gene of interest typically lies between these two AOX1 sequences. These features mark P.
pastoris as an exceptional choice as a recombinant expression system for the production of
heterologous proteins.
The most attractive characteristic of P. pastoris that makes it preferred over other
budding yeasts as a recombinant expression system is its disinclination to perform anaerobic
fermentation. Its preference for aerobic growth enables P. pastoris to be grown in a fermentor
(also known as a bioreactor) to achieve high cell-density cultures without producing toxic levels
of ethanol. The ability of P. pastoris to be cultured in a shaker flask or in a fermentor allows for
different scales of growth needed for a variety of applications. For example, small-scale research
purposes might induce growth in shake flasks, whereas industrial production of a recombinant
therapeutic will be done under large-scale fermentation conditions. A high cell density achieved
from fermentation conditions usually leads to high levels of recombinant expression. With
growth medium being solely composed of defined substances, void of any possibly toxins or
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pyrogens, it further represents it as a compatible expression system to produce human
pharmaceuticals (Lin-Cereghino and Cregg, 2000). P. pastoris has been used in the
biotechnology industry to produce a variety of protein therapeutics for clinical, industrial, and
research purposes, such as antigenic vaccines and monoclonal antibodies (Buckholz and
Gleeson, 1991; Cregg et al., 1987; Li et al., 2006; Lin-Cereghino and Cregg, 2000).
The Secretory Network
In order to illuminate the mechanisms behind secretion, extensive characterization of the
cellular constituents of P. pastoris has been performed. This primarily includes the secretory
network as well as cell wall integrity.
The eukaryotic secretory network encompasses the endoplasmic reticulum (ER), Golgi
apparatus, the vesicles that participate in transport, and the cell membrane. Compared to the
cytosol, these organelles possess oxidative environments that are needed to synthesize and
transport these proteins. The secretory network is a cellular pathway to shuttle proteins to their
final destination within or out of the cell. As ribosomes synthesize proteins intended for
secretion, detection of a signal peptide sequence (Lin-Cereghino and Cregg, 2000) directs cotranslational binding to the ER and subsequent completion of translation within the lumen (von
Heijne, 1990). Within the ER, proteins intended for secretion are correctly folded and modified
by enzymes. These include protein disulfide isomerase (PDI) (Wilkinson and Gilbert, 2004; Li
et al., 2010) that cross-links specific cysteine residues and oligosaccharyltransferases that
performs N-linked glycosylation (Kelleher and Gilmore, 2006).
One of the primary functions of the ER is to ensure that there is quality control of proper
protein folding prior to anterograde movement through the secretory pathway (Patil and Walter,
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2001). Unfortunately, accumulation of misfolded proteins within the ER lumen can occur; this
form of cellular stress from within the endoplasmic reticulum must be considered when
conducting heterologous protein expression. Proteins must be properly folded with high fidelity
in order to be ready for secretion out of the cell. When this does not occur, the Unfolded Protein
Response (UPR) is triggered. The UPR is a set of signal transduction pathways that, once
activated, can alleviate ER stress by attempting to maintain homeostasis (Patil and Walter, 2001;
Ron and Walter, 2007; Ron and Walter, 2011). UPR activation leads to expansion of the ER
membrane, as well as upregulated production of necessary protein-folding machinery in order to
accommodate the high volume of proteins. In most high-order eukaryotes, three unique branches
of signal transduction that compose the UPR work in parallel with their own mode of action
(Ron and Walter, 2011). However, only one of the three branches of UPR signaling works
solely in yeasts, including Pichia pastoris.
The highly conserved IRE1 (inositol requiring enzyme 1) branch of the UPR is the target
of interest when considering the ER stress exerted on yeast cells during recombinant expression;
in yeast, IRE1 activity induces the entirety of the UPR gene expression program (Ron and
Walter, 2011). The transmembrane serine-threonineF kinase Ire1p acts as a sensor for ER stress.
Unfolded protein accumulation in the ER leads to Ire1p oligomerization, and subsequent
autophosphorylation leads to activation of its endonuclease activity. The endonuclease Ire1p
then cuts HAC1 mRNA at two sites to remove an intron and the two exons are joined by Rlg1p.
Non-spliced “uninduced” HAC1 mRNA is not translated. However, the spliced “induced” HAC1
mRNA encodes Hac1p that is a transcriptional activator of UPR target genes (Patil and Walter,
2001). Hac1p controls the expression of several hundred genes (Delic et al., 2013). One of these
downstream targets includes the ER-resident foldase protein disulfide-isomerase. This ER
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chaperone aids newly produced proteins in achieving correct disulfide linkages. UPR activation
upon recombinant protein expression provides another facet to study in order to optimize
heterologous protein expression in P. pastoris. Having the proper three-dimensional structure is
essential for anterograde movement toward the next organelle in the secretory network - the
Golgi apparatus.
The Golgi is the site for protein maturation and sorting. Anterograde and retrograde
transport of proteins between the ER and the Golgi apparatus is facilitated by highly dynamic
membrane-bound transport vesicles (Kuehn et al., 1998). Proteins synthesized in the ER that are
intended for secretion enter the early compartment of the Golgi apparatus, cis cisternae, undergo
various post-translational modifications as it moves through the Golgi, and exit through the trans
cisternae. The Golgi complex is a dynamic, non-contiguous organelle in which anterograde
cargo vesicles from the ER either fuse together or with the Golgi (Lodish et al., 2008). The
cisternae that compose the Golgi apparatus are flattened membrane stacks. The various parts of
the Golgi have enzymes for specific post-translational modifications that are applied in a
retrograde manner during the proteins’ migration through the Golgi (Jackson, 2009). Despite
two models being proposed for transport through the Golgi (one proposes vesicular transport, yet
another suggests cisternal progression and maturation), the cisternae of the yeast Golgi
dynamically change the resident membrane proteins from the early cis to late trans composition
over time (Jackson, 2009; Matsuura-Tokita et al., 2006). The trans cisternae is the next site for
proteins that are intended for secretion and is where vesicle formation for delivery to the plasma
membrane occurs. One possibility is direct exocytosis of the cargo-containing vesicles into the
extracellular space for continuously secreted proteins. However, if a protein is not ready to be
secreted and must be stored within the cell, it will be packed into secretory vesicles in
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preparation for later exocytosis. For budding yeast species such as P. pastoris, secreted proteins
traverse through the periplasmic space and cell wall prior to exit into the extracellular space.
Yeast Cell Wall Integrity
The fungal cell wall is a structurally durable, yet dynamic, cellular structure. It acts as a
means of osmoregulation, can sense extracellular stress, detect changes in cell shape, and plays a
critical role in morphogenesis and remodeling (Levin, 2005; Jung and Levin, 1999; Levin, 2011).
The cell wall is a four-layered structure, and it is composed of four main structural
components: ß-1,3 glucan, ß-1,6 glucan, chitin (a-ß- 1,4 N-acetylglucosamine polymer), and
mannoproteins (a type of glycoprotein that contains mannose as a large portion of its weight).
The inner layer is composed primarily of glucan polymers and chitin, rendering it exceptionally
durable and elastic as the cell wall core (Levin, 2011). The outer layers, facing the periplasmic
space and extracellular space, are matrices of mannoprotein that are linked to inner glucan chains
(Levin, 2011; Kollár et al., 1997; Lipke and Ovalle, 1998). Because the cell wall is the first line
of encounter with the extracellular environment, cell wall integrity (CWI) is a proxy for potential
cell stress.
The cell wall integrity pathway is employed to manage cell wall perturbations and
potential intracellular effects; this can occur naturally during normal growth or due to
environmental changes. The CWI pathway has been extensively studied in Saccharomyces
cerevisiae. Cell wall stress is sensed at the plasma membrane by transmembrane surface sensor
proteins (i.e. S. cerevisiae’s Sig1p and Mid2p) that are coupled to the small GTPases, such as
Rho1p in S cerevisiae. In this example, Rho1p acts as a master regulator of the CWI pathway
because it controls many downstream effectors that lead to changes in actin cytoskeleton
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composition, proliferation, and cell wall biogenesis (Levin, 2005; Levin, 2011; Lipke and
Ovalle, 1998). One of these primary effectors is protein kinase C, which activates the MAP
Kinase (MAPK) cascade leading to the transcriptional output of the CWI pathway. Disruption of
this cascade, specifically protein kinase C, leads to cell wall integrity and cell viability being
compromised.
In S. cerevisiae, the PKC1 gene encodes the single PKC homolog and the structure and
activity of protein kinase C has been characterized (Schmitz et al., 2002; Reinoso-Martín et al.,
2003). It has multiple conserved regions that act as binding sites, which leads it to have a variety
of substrates with different downstream effects. A S. cerevisiae PKC1 deletion is lethal, but
viability can be achieved with osmotic support such as the addition of sorbitol. Because P.
pastoris has a single homolog of the PKC gene, it is an attractive target to study its role on cell
wall integrity and secretion in P. pastoris.
Yeast Proteomics and Mass Spectrometry
A rapidly growing area of biological research is proteomics, the comprehensive and
quantitative study of proteins. This includes the study of proteins’ physical structure and
function, as well as changes in protein expression that are due to biological changes or
disturbances (Anderson and Anderson, 1998). Proteomic studies aim to characterize genes and
cellular functions at the protein level. The utilization of proteomics has led to research advances
in protein-protein interactions, eukaryotic metabolic physiology, and the development of
therapeutic drugs. Proteomic studies include the identification and characterization of a single
protein, as well as complex populations of proteins from specific cells or tissues. These are
referred to as “targeted proteomics” and “shotgun proteomics”, respectively (Kolsrud et al.,
2012). Currently, the method of choice for many proteomic studies is mass spectrometry (MS).
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For the analysis of complex protein mixtures, MS is the primary method used. For targeted
proteomics, mass spectrometry can be applied to study protein-protein interactions, primary
amino acid sequencing, as well as post-translational modifications.
Although mass spectrometry can be utilized for many types of analytes, the focus of this
study will be on the analysis of proteins. All analytes, even proteins, must first be ionized in the
gas phase in order to be measured with a mass spectrometer. Whole proteins’ large molecular
weight makes MS analysis of intact proteins relatively difficult to detect. Therefore, an essential
step is the degradation of the proteins to smaller peptides, typically via proteases of known
function, to be used for mass spectrometry-based proteomics. For example, trypsin is a serine
protease that mainly cleaves peptide chains at the carboxyl side (C-terminus) of lysine and
arginine residues, which will produce peptides in a predictable manner. This protein digestion is
a final step in the protein sample preparation procedure that precedes analysis on a mass
spectrometer.
Typically, a mass spectrometer consists of three main compartments: an ion source that
ionizes the analytes, a mass analyzer that detects the mass-to-charge ratio (m/z) of the ionized
analytes, and a detector that detects the quantity of ions at each m/z ratio. For proteomic-based
mass spectrometry, two common techniques are used to ionize peptides prior to analysis:
electrospray ionization (ESI) is used for analyzing complex protein mixtures in solution (Fenn et
al., 1989), while matrix-assisted laser desorption/ionization (MALDI) is used to sublimate a
relatively simple protein mixture into the gas phase from a crystalline solid-phase matrix
(Aebersold and Mann, 2003). Because proteins are in solution for ESI-MS, it is usually coupled
with liquid chromatography for separation of the complex protein mixture based on ionexchange, size of the protein/peptide, and/or partitioning during chromatographic separation
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(Aebersold and Mann, 2003). The mass analyzer separates the ions according to their
corresponding m/z ratio. The mass analyzer also has an influence on the mass accuracy of the
ions, the resolution between two distinct m/z ratios, and sensitivity to the quantity of ions at each
m/z ratio. There are different types of mass analyzers with different functions, and each has its
own advantages and disadvantages over the others. Advanced mass spectrometers even combine
two or more mass analyzers in order to have a more comprehensive analysis of the ionized
peptides. ESI is usually coupled with ion trap analyzers that ‘trap’ the ionized peptides in a
compartment for a specific time period, and then they are detected for subsequent MS or MS/MS
analysis. MALDI is often coupled with time-of-flight (TOF, MALDI-TOF) analyzers that
accelerate the ions, and measures the time it takes them to hit the detector. The time of flight is
dependent on the mass-to-charge ratio, as well as their mass. Most importantly, it allows for the
generation of information-rich mass spectra from the ionized peptides, as well as even further
spectra of produced peptide fragments from the original ionized peptides (Kolsrud et al., 2012).
Subsequent fragmentation is performed on a prioritized selection of original ionized
peptides that show a high intensity during detection. Tandem mass spectrometry (MS/MS or
MS2) is then performed in the mass spectrometer. When selected for MS/MS, the isolated
peptide ion is fragmented via high-energy collisions with inert gas, and the fragments with
specific m/z ratios produced are illustrated via a second mass spectra. This MS/MS data, which
includes both MS and MS/MS spectra, are then used to compare protein sequence databases that
can produce hypothetically digested proteins and their produced fragments. From this in silico
comparison, the identity of the peptides - and the original proteins that they came from - can be
determined. This output is a “protein hit list”. Because the above-mentioned MS-based
proteomic techniques are dependent on protein sequence databases, it limits these types of
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proteomic research to species that have already been thoroughly sequenced with their data
available online. Recently, an extensive 1.3-hour proteomic analysis of the entire P. pastoris
proteome showcased the modern technological advancements of MS-based proteomic research
with the utilization of an Oribtrap Tribrid mass spectrometer (Hebert et al., 2014). The MS
analysis of the yeast proteome detected almost 4000 proteins in total.
As leading eukaryotic model organisms in biology, yeasts have been shown to be prime
candidates for eukaryotic proteomic research; their attractive characteristics include being singlecelled eukaryotes, as well as having been extensively studied and comprehensively sequenced,
such as S. cerevisiae (Ghaemmaghami et al., 2003; Ho et al., 2002) and P. pastoris (De Schutter
et al., 2009). P. pastoris is a host species for heterologous protein production that is no stranger
to MS-based proteomic analysis. Due to recombinant protein expression occurring via secretion,
the secreted proteome of P. pastoris is of central importance for characterization and
optimization of recombinant protein expression. The secretome has been defined to be the
proteome of the secreted proteins, including proteinaceous cellular machinery involved in
secretion (Kim et al., 2007). The secretome of wild type and recombinant methanol-induced,
fermentation cultures of P. pastoris has been previously characterized to illuminate the native
secretome, as well as how it is affected by recombinant protein expression (Huang et al., 2011).
Attempts to improve P. pastoris as a recombinant expression system have been made, such as
the identification and deletion of a native contaminant protein that led to no significant
differences in cellular growth and product formation (Heiss et al., 2013). The budding yeast
species is certainly a considerable candidate for mass spectrometry-based proteomic research of
eukaryotes.
Research Objectives and Aims
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For it to continue to serve as a host system for industrial applications, optimization of
heterologous secretion in P. pastoris must be held as a top priority. As of 2009, the yeast has
been utilized to express thousands of recombinant proteins and 500 pharmaceutical proteins
(Yang and Zhang, 2018). However, despite the success of the yeast as recombinant expression
platform, the system is faced with limitations that arise partly due to strain and product-specific
expression proteins (Yang and Zhang, 2018). Essentially, some recombinant proteins intended
for secretion are instead either retained in the cell or degraded. Another challenge is that
recombinant proteins expressed in P. pastoris may not have the same proper folding and posttranslational modifications as the native protein; thus, this leads to reduced activity of the protein
and even the potential for antigenic responses if the recombinant protein is intended for
therapeutic application. Continued research is needed to overcome these impediments of
optimized P. pastoris recombinant expression.
One avenue of exploration is the production of genetically modified strains that generate
relatively increased expression of recombinant proteins. Recently, certain P. pastoris strains
that displayed increased levels of secreted β-galactosidase reporter protein were developed
through random genomic disruption mutations (Larsen et al., 2013). Of these mutant REMI
(restriction enzyme mediated integration)-derived beta-galactosidase supersecretion (bgs)
strains, one strain displayed elevated secretion of a variety of different reporter proteins. This
strain, bgs13, had a random disruption of its BGS13 gene that led to the supersecretion
phenotype. It exhibited enhanced export of reporters such as horseradish peroxidase (HRP) with
its α-helical-rich and metal-containing structure, as well as human secretory leukocyte inhibitor
(SLPI) containing eight disulfide bonds.
The wild-type Bgs13p shares similarities with the protein kinase C of S. cerevisiae. The
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predicted amino acid sequence shares 50% homology and 68% similarity to the Pkc1p (Naranjo
et al., 2019). Because the Pkc1p is essential in the CWI pathway of S. cerevisiae, it initially
raised the question if the variant’s bgs13p (REMI-derived mutant protein) also influenced cell
wall integrity. Colorimetric assays for released vacuolar alkaline phosphatase (ALP) confirmed
a change in cell wall permeability, compared to the wild type cell. Treatment with the osmotic
stabilizer sorbitol restored cell wall function by inhibiting ALP release (Larsen et al., 2013).
Furthermore, the mutant bgs13 strain displayed higher sensitivity to Congo red and Calcofluor
white – compounds believed to interfere with cell wall assembly via binding to chitin –
compared to the wild-type strain, an indication of cell wall defects (Naranjo et al., 2019).
Transmission electron microscopy also identified the cell wall of the bgs13 cells to be thicker
compared to that of the wild-type parent cells. Therefore, it is possible that the mutant strain
differs in cell wall structure and integrity due to a change in function of the variant bgs13p.
The bgs13 allele may also play a role in the protein export and sorting process. A
difference in export of a recombinant hybrid protein composed of an N-terminal maltose binding
protein (MBP) and enhanced green fluorescent protein (EGFP) was seen in a past study (Moua et
al., 2016). This hybrid fusion protein was proteolyzed prior to secretion in the wildtype strain,
but secretion of MBP-EGFP was increased in the bgs13 strain. In the wild-type background,
intact MBP-EGFP was found to be localized in the vacuole via fluorescent microscopy. The
mutant bgs13 allele caused MBP-EGFP to be localized to parts of the secretory network prior to
secretion, as expected. With fewer MBP-EGFP being sent to the vacuole, it is possible that
improperly folded proteins are being secreted rather than being sent to the vacuole for
degradation.
To give insight into the chromosomal bgs13 mutation and its downstream effects, genetic
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characterization of the chromosomal mutation was performed. Characterization and sequencing
of the mutant bgs13 mRNA indicated that it was a Remi-bgs13 transcript, containing a 5’ UTR,
and 12 codons from the pREMI plasmid fused in-frame to codons 148 and after of the BGS13
coding sequence (Naranjo et al., 2019). Thus, it encoded the resulting Remi-bgs13p that led to
the supersecretion phenotype.
Attempts to generate a BGS13 knockout strain were unsuccessful, suggesting that the
BGS13 gene is essential for viability (Naranjo et al., 2019). As such, further studies on the bgs13
mutation cannot be performed in a knockout strain. Characterization of the mutant Remi-bgs13
gene indicated that it is recessive to the wild type BGS13 gene.
Because the Bgs13 peptide shares homology with S. cerevisiae Pkc1p, it was
hypothesized to have protein kinase C activity. Compared to the wild-type Bgs13 peptide (with
a C-terminal -myc-His6 fusion), cellular extracts containing the mutant Remi-bgs13 peptide
(with a C-terminal -myc-His6 fusion) displayed lower protein kinase C activity compared to
extracts containing the wild-type protein (Naranjo et al., 2019).
To test the hypothesis that decreased PKC activity led to increased secretion, a strain
which overexpressed the wild-type Bgs13p-myc-His6 protein was transformed with a plasmid
that expressed the SLPI reporter protein under the control of the AOX1 promoter.
Overexpression of Bgs13 peptide reduced secretion of SLPI approximately two-fold compared to
a strain with wild-type levels of Bgs13 peptide (Naranjo et al., 2019). These experiments
suggest that secretion is possibly regulated by protein kinase C activity of the Remi-bgs13
peptide. To determine if different cellular localization influenced secretion, C-terminal EGFP
fusions of wild-type Bgs13 and Remi-bgs13 peptides were produced. Fluorescent microscopy
observed that wild-type Bgs13p-EGFP was primarily localized at the neck and bud of dividing
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cells, whereas Remi-bgs13-EGFP was localized at the periphery of the cell (Naranjo et al.,
2019). As of the time of this writing, there is uncertainty whether the supersecretion phenotype
of the bgs13 strain is due to a change in protein kinase C activity or because of the difference in
localization of the mutant protein.
Overall, it is not apparent whether the cell wall structure changes are an effect of the mutant
bgs13 protein activity that is not related to increased protein secretion, or the cause of increased
secretion. The long-term goal of this research is to uncover information regarding the role of the
BGS13 gene in secretion and cell wall integrity, and how the mutation in the bgs13 strain leads to
increased secretion of recombinant proteins.
Here, I aim to examine the role of the encoded Bgs13 protein in the secretion pathway by
analyzing the mutant Remi-bgs13 protein’s effects that lead to a cell wall integrity defect,
increased secretion, and changes in the unfolded protein response. To address the cell wall
defect displayed by the mutant strain, I compare the population of proteins found in the
extracellular media, and those extracted from the cell wall via a dithiothreitol (DTT) extraction
for both wild type and bgs13 strains grown as shake flask cultures. I also examine the relative
cell wall porosity to give further insight on any possible changes or differences in cell wall
architecture of the two strains. Furthermore, due to the apparent differences observed in proteins
found in the extracellular medium and in cell wall structure, changes in the UPR were also
analyzed.
My results explicate, in part, the role of the modified Bgs13 protein and its activity
in the CWI pathway, its effects on the cell wall structure, and proteins that were found in the
extracellular medium. This research further illuminates how enhanced secretion can be achieved
in a valuable yeast recombinant host system such as P. pastoris.
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Chapter 2: Materials and Methods
Strain and Culture Conditions
All yeast strains used in this research, along with their corresponding genotypes, have
been listed in Table 1. The P. pastoris strains yJC100 and yGS115 were derived from the
original P. pastoris wild-type strain NRRLY11430 (Northern Regional Research Laboratories,
US Department of Agriculture, Peoria, IL). Yeast strains were cultured in YPD (1% yeast
extract, 2% peptone, 2% glucose), BMGY (buffered minimal medium with 0.5% methanol, 2%
peptone, and 1% yeast extract), BMMY (buffered minimal medium with 0.5% methanol, 2%
peptone, and 1% yeast extract), supplemented with the necessary amino acid(s) and 0.5%
methanol. Antibiotic resistance in yeast was verified with either 100 µg/mL Zeocin or 0.5
mg/mL G418. Yeast strains were grown at 30°C unless otherwise stated. Yeast cultures were
incubated in a New Brunswick Scientific C25 Incubating Shaker (Edison, NJ) at the indicated
temperature with shaking at 225 RPM.

Table 1: Pichia pastoris Strains
Strain

Genotype

yDT39

his4, met2, ß-gal

ybgs13

his4, met2, ZeoR¸ ß-gal

yJC100

Wild-type (haploid)
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Mass Spectrometry and Proteomics of Proteins Found in the Extracellular Media: Protein
Quantitation, Denaturation, Digestion, and Desalting
yDT39:pKanJV4 (wild-type,) and ybgs13:pKanJV4 cultures were grown overnight in
YPD medium to stationary phase. Optical density measurements were taken, and 5.0 OD600
units of each culture were pelleted and resuspended in 10 mL of buffered minimal medium with
dextrose (BMD) with histidine and methionine. Cultures were grown for 24 hours, then 50
OD600 units of wild-type culture and 100 OD600 units of bgs13 culture (to compensate for lower
growth rate) were pelleted, resuspended in 50 ml of buffered minimal medium with methanol
(BMM) with histidine and methionine. Cultures were induced for 48 hours at 28°C with shaking
(225 rpm), with methanol added to 0.5% 24 hours post-induction to compensate for losses from
evaporation and metabolism. At harvest, the OD600 of each culture was measured, cells were
centrifuged, and the supernatant was filtered (0.22 microns) to remove any remaining cell
particulate. Cell pellets and supernatants were immediately frozen and stored at -80°C.
Supernatant total protein concentrations were measured at 280 nm for both strains using a
Nanodrop spectrophotometer (Thermo Fisher Scientific, USA). Triplicate aliquots were made,
containing 2 mg of protein and each replicate was spiked (1 part spiked reference proteins : 500
part protein) with protein standards including bovine serum albumin ( BSA) (Pierce, USA) and
horse myoglobin (Sigma Life Science, USA) for subsequent label-free proteomics quantitation
analyses. Aliquots were precipitated using acetone (-20°C for 3 hours). Proteins were dried,
pelleted, then resuspend in 200 µL 3M urea/100 mM Tris (pH7.8). Precipitated protein
concentration was determined using the same methods above, then all samples were diluted to
standardize concentrations prior to proteomics sample preparation (0.5μg/μL; 50μg total protein).
Samples were reduced in 5mM dithiothreitol (DTT) (Gold Biotechnology, USA) for 30 minutes
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at room temperature (RT) and alkylated using 15 mM iodoacetamide (IAA) (Sigma, USA) for 30
minutes in the dark at RT. Unreacted IAA was quenched by adding 20 µL of 200 mM DTT and
incubating for an additional 30 minutes. Each reaction was then diluted with 3 volumes of sterile
water (~750 µL) to reduce urea concentration to < 2 M, then digested overnight at 37 °C using
trypsin (Promega, USA) (1 part trypsin : 10 parts protein). The digest was halted with the
addition of trifluoroacetic acid (TFA) and digested peptides were purified using OMIX C18 spin
columns according to the manufacturer’s instructions (Agilent Technologies, USA). Samples
were then diluted and lyophilized. Lyophilized samples were resuspended in 40 µL of 0.1%
formic acid in HPLC grade water; peptide samples were diluted to 150 ng/µL. All samples were
stored at −80 ◦C until mass spectrometry analysis.
HPLC-MS/MS
For each peptide sample, 5 μl were loop injected by a Dionex Ultimate 3000 autosampler
onto a reversed-phase trap column (Acclaim™ PepMapTM 100 C18 LC column; 75 μm i.d. x 2
cm, 3 μm particle size, 100 A pore size, Thermo Fisher Scientific, USA). Peptides were bound
and then eluted by using a reversed-phase analytical column (EASY-SprayTM C18 LC column;
75 μm i.d. × 15 cm, 100 A, Thermo Fisher Scientific, USA) held at 35°C for HPLC. Flow rates
were kept at 300 nl/min with each sequencing run set to 140 minutes. Solvents A and B were
0.1% formic acid in water and in acetonitrile, respectively. Solvent B was used as following: 3%
for 5 min, 3%–28% for 75 min, 28%–45% for 25 min, 45%–95% for 5 min, 95% for 5 min,
return to 3% for 5 min, followed by 2% for 25 min.
Mass spectrometry analysis was performed using an Orbitrap Fusion™ Tribrid™ mass
spectrometer equipped with an EASY-SprayTM ion source (Thermo Fisher Scientific, USA)
operated in a data dependent acquisition (DDA) manner via Xcalibur 4.0 software (Thermo
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Fisher Scientific, USA). Birefly, MS1 spectra were resolved by the Orbitrap; precursor ions
selected via DDA were quadrupole-filtered and fragmented using HCD. Instrument and data
acquisition settings were the same as previously reported (Khudyakov et al., 2018), with the
exception of the scan range (200-1400 Da), MS1 Orbitrap resolution (120,000), scan time (10130 minutes), MS2 Orbitrap resolution (30,000), and MS2 max injection time (150 ms).
Protein Identification
Analysis of tandem MS data was performed via Proteome Discoverer 2.2.0.388 (Thermo
Scientific, USA). Peptide spectra were searched against the complete UniProt SwissProt
database (downloaded on 2/13/2018) using SEQUEST. To identify any associated contaminants
that may have arose during sample preparation, spectra were searched against the common
Repository of Adventitious Proteins (cRAP, https://www.thegpm.org/crap/index.html). Search
parameters were the same as previously reported (Khudyakov et al., 2018). False discovery rate
(FDR) for peptide spectral matches (PSMs) and peptides were estimated by searching reversed
decoy databases that were generated from the Uniprot SwissProt and cRAP databases. Results
were filtered to remove identified contaminants. Peptides with target FDR < 1% were retained.
For proteins to be categorized as “unique”, they required 2 or more unique peptides that mapped
back to the spectra.
Protein Quantitation
Protein quantitation was performed using Proteome Discoverer 2.2.0.388 (Thermo
Scientific, USA). To align chromatographic runs for each biological condition, the feature
mapper node was used with a maximum retention time shift of 10 minutes, a mass tolerance of
10 ppm, and a minimum S/N threshold of 5 for feature linking mapping. MS2 data was filtered
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to retain only proteins that had 2 or more unique peptide hits and were identified in all samples
with high confidence. Biological replicates were grouped by condition. Quantitative
abundances were calculated, normalized to reference proteins (BSA and horse myoglobin), and
scaled with a label-free method using the Precursor Ion Quantifier node in Proteome Discoverer
2.2 (see methods). Abundance ratio calculations were made by using summed abundance values.
An analysis of variance (ANOVA) on individual proteins was performed to determine whether
protein abundances significantly (p ≤ 0.05) differed between samples. Ratio abundances and
log2fold-changes were calculated for the sample comparisons between wild-type and mutant
strains.
DTT Extraction of Cell Wall Proteins
Dithiothreitol (DTT)-extracts of wild-type (yDT39:pKanJV4) and bgs13
(ybgs13:pKanJV4) cells were prepared according to a previously described protocol (Scrimale et
al., 2009). Briefly, 40 OD600 cells were grown to early stationary phase (OD600∼10) overnight in

either BMM or BMMY, harvested by centrifugation (5 minutes, 300 ×g), washed twice with 10
mL water, and resuspended (0.5 OD600 equivalent/μl) in extraction buffer (50 mM Tris, pH 7.5,
and 5 mM DTT). As negative controls, both strains were resuspended in 50 mM Tris pH 7.5
alone. The cell suspension was shaken in a multi-vortex apparatus for 2 h at 4°C. The
supernatants were used for further analysis. An aliquot of the supernatant was removed, mixed
with 2X Laemelli sample buffer, boiled for 5 min at 100°C, and fractionated by SDSpolyacrylamide gel electrophoresis (PAGE) (BioRad mini-Protean TGX 4–20% gradient gel).
Fractionated proteins were visualized by silver stain according to the manufacturer's protocol
(Pierce Silver Stain kit; Thermo Scientific).
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Mass Spectrometry and Proteomics of Proteins Extracted from the Cell Wall: Protein
Quantitation, Denaturation, Digestion, and Desalting
From the DTT extraction of cell wall proteins, supernatant total protein concentrations
were measured at 280nm for both strains using a Nanodrop spectrophotometer (Thermo Fisher
Scientific, USA). Duplicate aliquots were made, containing 120 μg of protein. Aliquots were
precipitated using acetone (-20°C for 3 hours). Proteins were dried, pelleted, then resuspended
in 200 µL 3M urea/100 mM Tris (pH7.8). Precipitated protein concentration was determined
using the same methods above, then all samples were diluted to standardize concentrations prior
to proteomics sample preparation (approx. 0.21 μg/μL; 25 μg total protein). Prior to tryptic
digest sample preparation, each replicate was spiked (1 part spiked reference proteins : 500 part
protein) with protein standards including BSA and horse myoglobin for subsequent label-free
proteomics quantitation analyses. Samples were reduced in 5 mM dithiothreitol (DTT) (Gold
Biotechnology, USA) for 30 minutes at room temperature (RT) and alkylated using 15 mM
iodoacetamide (IAA) (Sigma, USA) for 30 minutes in the dark at RT. Unreacted IAA was
quenched by adding 20 µL of 200 mM DTT and incubating for an additional 30 minutes. Each
reaction was then diluted with 3 volumes of sterile water (~750 µL) to reduce urea concentration
to < 2 M, then digested overnight at 37 °C using trypsin (Promega, USA) (1:10, trypsin to
protein). The digest was halted with the addition of trifluoroacetic acid (TFA) and digested
peptides were purified using OMIX C18 spin columns according to the manufacturer’s
instructions (Agilent Technologies, USA). Samples were then diluted and lyophilized.
Lyophilized samples were resuspended in 40 µL of 0.1% formic acid in HPLC grade water;
peptide samples were diluted to 150 ng/µL. All samples were stored at −80 ◦C until mass
spectrometry analysis. Subsequent HPLC-MS/MS, protein identification and protein
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quantitation procedures and parameters were the same as those performed for the extracellular
media.
Cell Wall Porosity as Determined by a Polycationic Assay
The permeability of the wild-type (yDT39:pAM1) and bgs13 (ybgs13:pAM1) cell wall
was measured using a protocol adapted for several different fungal species (Walker et al., 2018).
The assay was performed on a mutant strain (FWK1) with a known cell wall defect in the OCH1
gene, and its parent strain (Ku70) for comparison (Krainer et al, 2013). Briefly, overnight
cultures of cells grown in YPD were diluted in fresh medium to 0.1 OD600 at 28°C and then
allowed to grow to approximately 1 OD600. For each strain, approximately 8 OD600 of cells were
centrifuged @ 3500 xg for 7 min at room temperature. The supernatant was discarded, and the
cell pellet was washed three times with 0.22 μm sterile-filtered milliQ water. The cells were
then resuspended in 10mM Tris, pH 7.4 to a final OD600 of approximately 2.0 and the
resuspension was divided into three 1.5 mL centrifuge tubes with an approximate volume of 0.9
mLs each. To each 0.9 mL cell suspension, the following were added, either: 1) 100 µL of 10x
poly-L-lysine (Sigma-Aldrich, 30-70 kD, 100 ug/mL in 10mM Tris, pH 7.4) 2) 100 µL of 10x
DEAE Dextran (Sigma-Aldrich, 500 kD, 50 ug/mL in 10mM Tris, pH 7.4) or 3) 100 µL of
10mM Tris, pH 7.4. The cell suspensions were then incubated at 28°C for 30 min at 200 RPM in
shaking incubator. The cells were spun down for 2 min at 10,000 xg two times to isolate the
supernatant. The A260 reading of each supernatant was taken to measure the UV absorbing
compounds, using the supernatant from cells incubated in only 10 mM Tris buffer, pH 7.4 as a
blank. The assay was performed on the bioreplicates samples in duplicate. The relative cell wall
porosity was defined (%) = [(A260 of DEAE-dextran)/(A260 of poly-L-lysine)] × 100% (Tang et
al., 2016).
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Cytoplasmic and Membrane-Associated Protein Extraction from P. pastoris Strains
yDT39:pAM1 and ybgs13:pAM1
Protein extractions from soluble cytoplasmic and insoluble membrane-associated
fractions were performed according to a previous extraction procedure (Damasceno et al. 2009).
Cells (OD600=4) stored at -80°C were thawed, washed in phosphate-buffered saline (PBS) pH
7.4, and then resuspended in yeast breaking buffer [(50 mM sodium phosphate, pH 7.4, 1 mM
PMSF, 1 mM EDTA, and 5% (v/v) glycerol]. An equal amount of acid-washed glass beads was
added, and cells were lysed by vortexing at max speed ten times for 1 minute with 1-minute
intervals on ice. The lysate was centrifuged at 10,000 xg for 30 minutes at 4°C. The
supernatant, containing cytoplasmic proteins, was collected and designated as the cytoplasmic
fraction. The remaining pellet with cell debris and glass beads was resuspended in 100 μL of
breaking buffer containing 2% (w/v) SDS and centrifuged at 4000 xg for 5 minutes at 4°C. The
supernatant was collected as designated as the membrane associated fraction. The extraction and
detection of PDI was also performed on yJC100:pAM1:pPICZPDI as a positive control, a strain
which overexpresses PDI (Li et al., 2010).
Polyacrylamide Electrophoresis and Western Analysis
Either equivalent amounts of protein or volumes of extracellular medium from equivalent
numbers of cells were run on sodium dodecyl sulfate-polyacrylamide gels (SDS-PAGE). The
gels were either stained for total protein visualization using either the PageBlue (Thermo
Scientific, Rockford, IL), Silver Snap II (Pierce, Rockford, IL) stains, or analyzed by western
analysis.
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For westerns, proteins were transferred onto nitrocellulose membrane using a an iBlot®
apparatus (Life Technologies, Carlsbad, CA) according to the manufacturer’s instructions.
Immunoblots were processed as follows. The membrane was soaked in 1X PBS while the SNAP
ID 2.0 Protein Detection System blot holder (Millipore, Billerica, MA) was wet with water. The
nitrocellulose membrane was placed on the blot holder, followed by a spacer sheet. The closed
blot holder was placed onto the SNAP ID apparatus attached to a vacuum. With the vacuum
turned on, 30 mL of I-Block (ThermoFisher Scientific, St. Louis, MO) solution (1xPBS, 0.2% IBlock, 0.1% Tween 20) was added to the membrane. The vacuum was turned off before
incubating the membrane with 3 mL of I-Block solution containing the appropriate volume of
primary antibody. After 10 minutes of incubation with the primary antibody, the vacuum was
turned on again, and the membrane was washed three times with a total of 120 mL wash buffer
(1X PBS, 0.1% Tween 20). The membrane was then incubated in 5 mL of I-Block containing
the goat anti-mouse or goat anti-rabbit secondary antibody (Applied Biosystems, Foster City,
CA) for 10 minutes with the vacuum off. Afterwards, the membrane was washed three times
with wash buffer again, as previously described, before it was incubated for 5 minutes in a petri
dish containing 20 mL of femtoLUCENT™ PLUS-AP 1X TBST (G-Biosciences, St. Louis,
MO). A flat plastic-wrap surface was prepared where 2 mL of the femtoLUCENT™ PLUS-AP
detection reagent was added dropwise onto the membrane. After 5 minutes of incubation at
room temperature, the detection reagent was drained off. The membrane was placed into a
plastic envelope or wrap and developed using the Bio-Rad ChemiDoc XRS+ Imaging System
(Hercules, CA) with exposure times of 1-2 minutes. Signals were quantified with Bio-Rad
ImageLab software.
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Chapter 3: Results
ESI/MS/MS Analyses of Culture Media of 28°C Shake Flask-Grown Cultures
Initial research on the bgs13 strain led to the observation of apparent differences in cell
wall integrity and secretion, compared to the wild-type strain. A previous experiment had shown
an increase in the levels of four out of five reporter proteins in the bgs13 strain. Therefore,
analyzing quantitative differences in the population of proteins found in the extracellular media
(ECM) was the first approach in the characterization of the mutant bgs13 strain. To identify and
quantitate the relative abundance of proteins present in 28°C shake flask culture medium of both
mutant bgs13 and DT39 (wild-type; WT) cultures, samples of each strain’s post-induction ECM
were collected, solubilized in 3M urea, and subjected to an overnight digest with trypsin. Both
strains were engineered to recombinantly express an MBP-EGFP fusion reporter protein, and its
export was studied previously (Moua et al., 2016). Label-free quantitative mass spectrometry
was performed by spiking the extracellular media from equal number of cells with a known
amount of protein standards, bovine serum albumin (BSA) and horse myoglobin (1-part spiked
reference proteins : 500-part protein). The produced peptides were then separated via nanoliquid chromatography, eluted and ionized by ESI for MS/MS analysis. The MS fragmentation
spectra were searched against the entire Uniprot Swissprot database. Between wild-type and
bgs13 protein samples, relative protein abundance was calculated via ProteomeDiscoverer 2.2 by
detecting and relating peptide signals at the MS1 level. Within both wild-type and mutant bgs13
extracellular media, a total of 335 proteins were identified with high confidence (after filtering of
the contaminants identified via the cRAP database), with 2+ unique peptides mapping back to
each identified protein, across all six technical replicates (Table 2, Figure 1). Eleven proteins
were identified to be either uncharacterized or hypothetical proteins after BlastP analyses.
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Table 2: Summary statistics of proteins found in the extracellular media (ECM)
Proteins identified

949

Proteins with >2 unique peptides

335

Protein groups

613

Peptide spectral matches (PSMs)
MS/MS spectra

36,268
106,346

Since the bgs13 strain is hypothesized to be a possible supersecreter strain, the relative
abundance of the 335 identified proteins found in the post-induction extracellular media of both
strains was determined. Differential abundance of an identified protein was calculated as the
ratio of the protein’s grouped (i.e. average) abundance in the bgs13 ECM to the protein’s
grouped abundance in the wild-type ECM. A fold change in differential abundance of proteins
found was calculated by taking the log2 of the abundance ratio. The majority of identified
proteins were found to be higher in abundance in the bgs13 strain (Figure 1).
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Figure 1: Differential protein populations found in the extracellular media of shake flask cultures
grown at 28°C. A volcano plot illustrates the differential abundance of proteins found in the
extracellular media post-methanol induction. Differentially abundant proteins of statistical
significance (p ≤ 0.05) are shown in red (lower abundance in bgs13) and green (higher
abundance in bgs13). X-axis, log2(fold-change): fold-change in abundance between the two
populations, wild-type and mutant bgs13. Y-axis, -log10(p-value): The statistical significance in
the fold-change of abundance. Fold changes are calculated by taking the log2 of the abundance
ratio (bgs13:wild-type); for each strains’ three technical replicates, the abundance of each
identified protein was grouped (averaged) for use in the abundance ratio and fold-change.
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Of the recombinant hybrid reporter protein MBP-EGFP, enhanced green fluorescent
protein (EGFP) and maltose binding protein (MBP) were found to have the highest abundance
ratios with 24.043 and 17.524, respectively. Through manual annotation of the protein hits
provided from Proteome Discoverer 2.2, nine proteins that were previously characterized as
secreted or contain a signal peptide sequence were identified (Table 3). These were found in a
past proteomic study on the secretome of methanol-induced P. pastoris cultures (Huang et al.
2011). These proteins include cell wall-associated proteins such as 1,3-ß-glucanosyltransferase
(ATY40_BA7501626) and exo-ß-1,3-glucanase (EXG), as well as other native secreted proteins
such as vacuolar proteases (BA75_01312T0, PRB1 and BA75_03408T0, PEP4) and a known
host-cell contaminant (BA75_03408T0, PRY2). Of the 335 proteins that were identified in both
strains’ extracellular media, many are of intracellular origin. Differentially abundant
intracellular proteins, those found at higher levels in bgs13 ECM, include those associated with
the UPR (Kar2p, KAR2; Protein disulfide isomerase, PDI) and protein folding and aggregation
(BA75_00603T0, CPR6; BA75_00961T0, SGT2; BA75_01760T0, HSP104; BA75_02652T0,
STI1; BA75_00236T0, ATY40_BA7500236). Furthermore, the bgs13 ECM had alcohol oxidase
(BA75_04486T0, ATY40_BA7504486, abundance ratio = 2.041; BA75_03165T0,
ATY40_BA7503165, abundance ratio = 1.461) in higher abundance than in the wild-type ECM.
The observed differential abundance of the identified proteins between the two strains indicates
that there are underlying factors at work within the cell that lead to differences in the protein
populations found in the extracellular media after induction of heterologous expression.

A0A1B2JDF4

A0A1B2JDU3

A0A1B2J755

A0A1B2J5U4

A0A1B2J758

Q2TCV2

A0A1B2JF94

BA75_02994T0

BA75_03273T0

BA75_01624T0

BA75_00070T0

BA75_01312T0

Exo-ß-1,3-glucanase

BA75_03408T0

BA75_02022T0

1,3-ßglucanosyltransferase

A0A1B2J7P6

A0A1B2JAX4

Protein name

Uniprot entry
code (Accession)

YDR262W (K.
pastoris)

ATY40_BA7503273
(K. pastoris)

ATY40_BA7501624
(K. pastoris)

PRY2 (K. pastoris)

PRB1 (K. pastoris)

EXG (K. pastoris)

PEP4 (K. pastoris)

ATY40_BA7502022
(K. pastoris)

ATY40_BA7501626
(K. pastoris*)

Gene name

Putative protein of unknown function

Mitochondrial outer membrane and cell
wall localized SUN family member

Cell wall protein with similarity to
glucanases

Sterol binding protein involved in the
export of acetylated sterols

Vacuolar proteinase B (YscB), a serine
protease of the subtilisin family

Involved in cell wall beta-glucan
assembly and maintenance

Vacuolar aspartyl protease (proteinase
A)

Cell wall protein that contains a
putative GPI-attachment site

Involved in cell wall biosynthesis and
morphogenesis

Description

0.667`

0.724

0.728

1.014

1.075

1.306

1.472

2.840

4.268

Abundance ratio
(bgs13/WT)

Table 3: Summary information of identified representative proteins in the extracellular media that contain a signal peptide (SP)
sequence.
*Komagataella pastoris (K. pastoris) is the reassigned name to Pichia pastoris and is used by the Unirprot Swissprot database.
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Extraction and Analysis of Cell Wall Proteins
Silver stain of DTT-extracted cell wall proteins. Because the bgs13 strain showed
compromised cell wall integrity in previous work (Larsen et al., 2013), differences in the cell
wall structure may reveal more information on possible factors that could be leading to the
differential abundance of proteins in the extracellular media. To characterize the structural
differences in the cell wall between the wild-type and mutant strains, an analysis of extractable
proteins from the cell wall was utilized. Dithiothreitol (DTT) was used as the extraction agent
due to its ability to reduce and release dithiol-linked proteins of the cell wall. It is expected that
defects in the cell wall composition or structure would lead to an increase in DTT-extractable
proteins (Scrimale et al., 2009). To perform the DTT extraction, wild-type (yDT39:pKanJV4)
and bgs13 (ybgs13:pKanJV4) cells, which both expressed MBP-EGFP, were first separated from
the extracellular media via centrifugation, washed with sterile-filtered water, and incubated in an
extraction buffer containing 50mM Tris, pH 7.5 and 5mM DTT. The supernatant fractions were
analyzed by SDS PAGE.
An initial silver stain of fractionated DTT-extracted proteins derived from an equal
number of wild-type and bgs13 cells displayed a visibly increased amount of extractable proteins
from the mutant cells (Figure 2). Novel protein bands seemed to be present from the bgs13
extracts, and other protein bands appeared to increase in concentration from wild-type to bgs13
such as those at 40-45 kDa. Cells grown in BMM media were compared with those grown in
BMMY media containing yeast extract, with no observable outstanding differences. The
increased amount of proteins liberated from the bgs13 cells gave reason to analyze the DTTextracted cell wall proteins as the next protein population for mass spectrometry analysis.
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Figure 2: SDS-PAGE analysis of the proteins extracted from the cell wall, post-induction. After
fractionation via SDS-PAGE, a silver stain was performed on proteins that were dithiothreitol
(DTT)-extracted from the cell wall after removal of the extracellular media. Lanes: (1)
molecular ladder; (2 and 3) wild-type, BMM media; (4 and 5) bgs13 mutant, BMM media; (6
and 7): negative control strain harboring an empty vector, yJC100:pPICZα, BMM media; (8):
wild-type, BMMY media; (9): mutant bgs13, BMMY media

ESI/MS/MS of DTT-extracted cell wall proteins. The protein population extracted
from the cell walls of both wild-type and mutant bgs13 underwent sample preparation, tryptic
digest and subsequent data analysis as was performed on the extracellular media. A total of 359
proteins were identified in the extracts of both strains with high confidence (after filtering of the
contaminants identified via the cRAP database), with >2 unique peptides mapping back to each
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identified protein, across all four technical replicates (Table 4, Figure 3). 23 proteins were
identified to be either uncharacterized or hypothetical proteins after BlastP analyses.

Table 4: Summary statistics of proteins found from the DTT-extraction of the cell wall
Proteins identified

1,148

Proteins with >2 unique peptides

359

Protein groups

747

Peptide spectral matches (PSMs)

26,247

MS/MS spectra

79,448

In order to characterize any observable differences in cell wall integrity or composition
that emerged due to the Remi-bgs13 hybrid protein, I aimed to quantitate the relative abundance
of the 359 proteins extracted from the cell wall in both strains, bgs13 and wild-type. The
differential abundance of the 359 identified cell wall-extracted proteins was obtained, and fold
changes in the differential abundance are graphically represented on a volcano plot (Figure 3).
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Figure 3: Differential protein populations found from the DTT-extraction of the cell wall from
cells grown in shake flask cultures at 28°C. A volcano plot illustrates the differential abundance
of proteins extracted from the cell wall post-methanol induction. Differentially abundant
proteins of statistical significance (p ≤ 0.05) are shown in red (lower abundance in bgs13) and
green (higher abundance in bgs13). X-axis, log2(fold-change): fold-change in abundance
between the two populations, wild-type and mutant bgs13. Y-axis, -log10(p-value): The
statistical significance in the fold-change of abundance. Fold changes are calculated by taking
the log2 of the abundance ratio (bgs13:wild-type); for each strains’ three technical replicates, the
abundance of each identified protein was grouped (averaged) for use in the abundance ratio and
fold-change.
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Similar to those found in the extracellular media, the majority of the 359 proteins were
identified to be more abundant in the mutant bgs13 cells relative to the wild-type extraction. The
two parts of the hybrid recombinant reporter protein, EGFP and MBP, were found to be higher in
abundance in the bgs13 strain (abundance ratios of 2.262 and 1.977, respectively), but they were
not the proteins with the highest abundance ratios. Through manual annotation of the protein
hits provided from Proteome Discoverer 2.2, eight previously characterized cell-wall associated
proteins were identified (Table 5). These include multiple isoforms of 1,3-ßglucanosyltransferase with varying abundance ratios ranging from 3.710 to 0.418
(ATY40_BA7501626, GAS1, GAS3). Two of the three 1,3-ß-glucanosyltransferase isoforms
encoded by ATY40_BA7501626 and GAS1 displayed higher abundance in the bgs13 extract.
Other proteins that are involved with cell wall assembly and/or maintenance include endo-ß-1,3glucanase (BA75_03970T0, BGL2), chitin transglycosylase (BA75_04772T0,
ATY40_BA7504772), a cell-wall associated aspartic protease (BA75_00420T0, YPS7) and an
uncharacterized glucanase-like protein (BA75_01624T0, ATY40_BA7501624) (Table 5). Many
of the 359 proteins that were identified in both strains’ cell wall extraction were of intracellular
origin, such as key proteins involved in the UPR and protein folding including protein disulfideisomerase (PDI, abundance ratio = 1.70) and Kar2p (KAR2, abundance ratio = 2.292), which
were found to be more abundant in the bgs13 extraction. Furthermore, proteases with SP
sequences (BA75_01312T0, PRB1; BA75_03727T0, LAP4; BA75_03408T0, PEP4;
BA75_05092T0, ATY40_BA7505092) and one with chaperone activity (BA75_02264T0,
NMA111) were identified in the extraction from both strains. Alcohol oxidase (BA75_03165T0,
ATY40_BA7503165, abundance ratio = 4.510; BA75_04486T0, ATY40_BA7504486,
abundance ratio = 1.877) was higher in abundance in the bgs13 mutant. Due to the apparent
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differences in protein abundance obtained from the mass spectrometry analysis, I aimed to
further characterize the cell wall by investigating any observable difference in cell wall porosity
in relation to the Remi-bgs13 hybrid protein.

BGL2 (K. pastoris)

BA75_00420T0

BA75_04772T0
BA75_01624T0
1,3-ßglucanosyltransferase
BA75_03970T0

A0A1B2J7D2

A0A1B2JJE0

A0A1B2J755

A0A1B2JGR3

A0A1B2JF97

GAS3 (K. pastoris)

1,3-ßglucanosyltransferase

A0A1B2J5A4

ATY40_BA7501624
(K. pastoris

ATY40_BA7504772
(K. pastoris)

YPS7 (K. pastoris)

GAS1 (K. pastoris)

ATY40_BA7501626
(K. pastoris)

1,3-ßglucanosyltransferase

A0A1B2J7P6

ATY40_BA7502022
(K. pastoris*)

Gene name

BA75_02022T0

Protein name

A0A1B2JAX4

Uniprot entry
code (Accession)

Endo-ß-1,3-glucanase; involved in
incorporation of newly synthesized
mannoprotein molecules into the cell
wall

Involved in cell wall biosynthesis and
morphogenesis

Cell wall protein with similarity to
glucanases

Chitin transglycosylase

Putative GPI-anchored aspartic
protease; involved in cell wall growth
and maintenance

Involved in cell wall biosynthesis and
morphogenesis

Involved in cell wall biosynthesis and
morphogenesis

Cell wall protein that contains a
putative GPI-attachment site

Description

0.406

0.418

0.657

0.721

0.940

1.629

3.710

4.073

Abundance ratio
(bgs13/WT)

Table 5: Summary information of identified representative cell-wall associated proteins from the DTT-extraction of the cell wall.
*Komagataella pastoris (K. pastoris) is the reassigned name to Pichia pastoris and is used by the Unirprot Swissprot database.
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Cell Wall Porosity
We hypothesized that enhanced secretion may have resulted from an increase in cell wall
porosity due to the structural changes detected by the DTT assay. In order to observe differences
in strains engineered for recombinant protein expression, strains that expressed SLPI-myc-6xHis
under the AOX1 promoter, yDT39:pAM1 and ybgs13:pAM1, were chosen for the assay.
Measurements of the cell wall porosity of the two P. pastoris strains, utilized two polycationic
polymers with differently sized hydrodynamic radii. DEAE-dextran and poly-L-lysine both
enhance the permeability of the cell membrane, thus leading to release of cytosolic UVabsorbing compounds such as nucleic acids. Poly-L-lysine (30-70 kDa, molecular mass) has a
relatively small hydrodynamic radius and causes cell leakage independent of cell wall porosity.
DEAE-dextran (500 kDa, molecular mass) causes cell leakage but its larger hydrodynamic radius
limits its passage through the cell wall, making its effectiveness dependent on the cell wall
porosity. The relative cell wall porosity was defined (%) = [(A260 of DEAE-dextran)/(A260 of
poly-L-lysine)] × 100%. Therefore, a difference in cell wall porosity via this assay based on
measurement of cell lysis was determined by the ratio between DEAE-dextran- and poly-Llysine-induced release of UV-absorbing compounds measured at 260nm. For all strains, equal
amounts of cells were separated from the extracellular media supernatant, washed, and then
incubated in buffer containing either 1x DEAE Dextran or 1x poly-L-lysine. The A260 of the
supernatant was measured for the relative porosity calculations. In addition to the yDT39 and
bgs13 strains, the polycationic porosity assay was also performed on a strain with a known cell
wall defect, FWK1, along with its parent strain as controls. The FWK1 strain contains a deletion
of the OCH1 gene that encodes a mannosyltransferase. The results on these control strains
validated the cell wall porosity (Table 6): compared to its parent, the FWK1 strain with the cell
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wall defect displayed a ten-fold increase in relative porosity. Contrary to our expectations, the
bgs13 cell walls were found to be about 9.5% less porous than that of the wild-type cells (Table
6).

Table 6. Relative cell wall porosity as determined by a polycationic assay. A strain (FWK1)
with a known cell wall defect caused by a deletion of the OCH1 gene, and its parent strain
(Ku70) were also analyzed for comparison. Data reflects the averages of duplicates.
Strain

Relative cell wall porosity %

yDT39:pAM1

31.9 ± 3.11%

ybgs13:pAM1

22.4 ± 2.92%

Ku70

12.2 ± 4.94%

FWK1

122 ± 14.0%

Changes in the UPR: Intracellular Protein Disulfide Isomerase (PDI) Expression
The apparent differences in relative protein abundance detected in the extracellular media
and cell wall extracts, as well as the difference in cell wall porosity, can potentially be related to
changes in the unfolded protein response. Furthermore, the presence of Kar2/Bip and protein
disulfide isomerase protein (Pdip) in the ECM and cell wall suggests that the Remi-bgs13 protein
leads to inefficient retention of these proteins in the ER, or that the release of these chaperones
into these two locations is due to cell lysis caused by an altered cell wall. Because Pdip was
found in higher abundance in the bgs13 ECM and cell wall, it raised two possible scenarios: 1) If
the mutant Remi-bgs13 protein led to increased Pdip expression, and sent Pdip to the cell wall
and ECM due to inefficient retrieval, then the level of intracellular Pdip would be comparatively
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similar inside the wild-type and bgs13 cells, or 2) If Pdip was overexpressed, accumulated and
retained in the ER and its release only occurred after cell lysis, then the intracellular levels of
Pdip would be greater in the bgs13 extraction. To investigate this aspect of the UPR, potential
differences in the expression levels of the downstream UPR target, protein disulfide isomerase,
were examined between wild-type and bgs13 cells after induction of recombinant protein
expression.
As a positive control, a strain overexpressing PDI from the AOX1 promoter
(yJC100:pAM1:pPICZPDI) was included in our study. Equal number of cells from
yDT39:pAM1, ybgs13:pAM1, and the control were subject to protein extraction. Cells were
lysed with glass beads and after centrifugation, the supernatant was collected as the “soluble”
fraction. The remaining pellet was then extracted with breaking buffer and the resulting proteins
were designated as the “insoluble membrane-associated fraction”. Approximately equal amounts
of protein from each strain’s soluble and insoluble fractions were subjected to western blot
analysis detection with a primary antibody against PDI protein (Pdip).
While the soluble fractions did not have significant amounts of Pdip, the insoluble
membrane-associated fractions contained detectable levels of PDI (Figure 4). This is likely due
to PDI being enclosed within the ER. The positive control from yJC100:pAM1:pPICZPDI,
produced the strongest intensity. Pdip had a higher detectable intensity in the wild-type strain
than in bgs13 (Figure 4). However wild-type and bgs13 Pdip levels were considered to be
comparable, suggesting that similar amounts of ER-residential protein disulfide isomerase are
present in both the wild-type and bgs13 cells. Based on these results, this portion of the UPR
was not upregulated in the bgs13 strain.
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Figure 4: Intracellular protein disulfide isomerase (PDI) expression levels in P. pastoris strains
after methanol-induced recombinant protein expression. A) Immunoblot of intracellular PDI
levels extracted from insoluble membrane-associated fractions. Strains from left to right, “WT”
(wild-type): yDT39:pAM1, “bgs13”: ybgs13:pAM1, “(+) control”: yJC100:pAM1:pPICZPDI.
Exposure time: 5 minutes. B) Quantitative intensity of each strain’s detected PDI protein band.
Adjusted volumes were calculated using a global background subtraction of a single background
volume (global volume subtraction calculates a single background intensity for the entire
membrane). Area of detection (mm2): 19.6181, number of pixels: 468, mean background
(intensity): 1442.57.
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Chapter 4: Discussion
Study Objectives
Pichia pastoris has been established as a reputable host for recombinant protein
expression. As a single-celled eukaryote with the capabilities of achieving scalable growth and
expression as well as programmed export of a recombinant gene product via secretion, it is at the
forefront of expression systems used for biopharmaceutical production (Looser et al., 2015).
Nevertheless, P. pastoris has the potential to be further optimized in order to heterologously
express a wider variety of proteins, which can be attained by a deeper understanding of the
yeast’s mechanisms of secretion. Unfortunately, the most prominent limitation to this expression
system is the occurrence of some recombinant proteins intended for secretion being either
retained or degraded in the cell; this results partly from the proteins not achieving their intended
native folding or correct post-translational modifications. One way of addressing this issue is to
engineer genetically modified strains that can generate increased expression of recombinant
proteins. The mutant bgs13 strain, produced from a genomic disruption mutation (Larsen et al.,
2013), displayed increased secretion of multiple recombinant reporter proteins – an indication
that it may be a possible universal supersecreter strain. From the mutation in the BGS13 gene
that gave rise to this strain, the encoded Remi-bgs13 protein is a primary target to examine the
underlying mechanisms that are involved in secretion. Illuminating the effects of the mutant
Remi-bgs13 protein on enhanced secretion, cell wall integrity and changes to the UPR will
provide insight into the role of the encoded Bgs13 protein in secretion.
Proteins Found in the Extracellular Media
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The characterization of the secretion differences between the wild-type and bgs13 strains
began with a quantitative analysis of proteins found in the extracellular media after methanolinduced recombinant protein expression. The identification and characterization of proteins in
the extracellular media was performed using a label-free quantitative mass spectrometry
approach. In this regard, the relative quantity of the proteins present only in both strains were
obtained. From the post-induction culture supernatant samples grown at 28°C, 335 proteins were
identified in both the extracellular media of wild-type and bgs13 strains (Table 2; Supplemental
Table 1). This high number of proteins is composed mostly of those with an expected
intracellular subcellular location and/or origin, which is possibly due to cell lysis that occurs
during the process of growth in the shake-flask cultures. A previous proteomic analysis of
fermenter grown, methanol-induced cultures also identified proteins of intracellular origin in the
extracellular media (Huang et al., 2011). However, they did not identify as many as found here.
Therefore, the higher number of intracellular proteins found in the extracellular media of our
shake-flask cultures may be due to greater sensitivity that comes with improved instrument
technology or the lack of control of growth conditions that bioreactors maintain. For shake-flask
cultures, temperature and the agitation of the incubator are the main parameters that can be
controlled; bioreactors can regulate wide range of growth conditions, such as the feeding of
growth media, monitoring of methanol levels, oxygen levels, and pH monitoring (Cregg, 1999).
A lack of constant, fixed growth conditions likely leads to a higher occurrence of cell lysis that
causes a variety of intracellular proteins to be released into the extracellular media.
As expected, the hybrid reporter protein, MBP-EGFP, were found to be the most
differentially abundant proteins between bgs13 and wild-type strains, a result confirmed by
western analysis (data not shown). Alcohol oxidase, a resident enzyme of peroxisomes, was
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identified in the ECM of both strains because it is induced to an extremely high level when P.
pastoris is grown on methanol as the sole carbon source (Lin-Cereghino and Cregg 2000).
However, alcohol oxidase was found to be twice as abundant in the bgs13 as the wild-type ECM.
Furthermore, the majority of the 335 identified proteins were found to have an abundance ratio
(bgs13/wt) of 1.0 or higher. As a reminder, the differential abundance of a protein was
calculated as the ratio of the protein’s average abundance in the bgs13 ECM to the protein’s
average abundance in the wild-type ECM. Many secreted proteins, identified in previous
publications (Huang et al., 2011; Mattanovich et al., 2009) were identified in this study (Table
2). Cell-wall associated proteins 1,3-ß-glucanosyltransferase (ATY40_BA7501626, abundance
ratio = 4.268) and BA75_02022T0 (ATY40_BA7502022, abundance ratio = 2.840) were found
to be considerably differentially abundant. This may be related to the role of the Bgs13 protein
in cell wall integrity.
Vacuolar proteases (PEP4, PRB1) were also identified to be more abundant in the bgs13
strain. The increased release of these proteases by the mutant raises concern for the expression
and purification of recombinant protein expression; higher protease levels in the extracellular
medium may lead to secreted proteins being degraded. Therefore, to further optimize the bgs13
strain for recombinant protein expression via secretion, the implementation of proteasedeficiency should be explored (Cereghino and Cregg, 2000; Idiris et al., 2006).
Interestingly, the endogenous protein secreted at highest levels by wild-type P. pastoris,
a protein (Heiss et al., 2013) encoded by PRY2, was found to not be differentially secreted, with
an abundance ratio of 1.017. This peptide is considered a contaminant when trying to purify a
recombinant protein. Despite the PRY2 gene product being a native secreted protein that can be
induced by different stress conditions and upregulated by the UPR (Heiss et al., 2013), the
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mutation in the BGS13 gene did not have a considerable effect on its export into the extracellular
media. This proves to be a good indication that the bgs13 strain does not increase the export of
all proteins intended for secretion. Not enhancing the secretion of a native contaminant peptide
certainly is an attractive aspect of the bgs13 secretion strain.
Although a high number of intracellular proteins were identified in the media, many were
of interest. For example, UPR-associated proteins such as Kar2/Bip and protein disulfide
isomerase (Pdip) were found to be higher in abundance in the bgs13 ECM. In a P. pastoris
strain that overexpressed the UPR-inducing HAC1 gene, leading to an increase in the UPR, both
Pdip and Kar2/Bip were identified in the culture supernatant (Guerfal et al., 2010). Another
study also found that full-length and truncated Kar2/Bip and Pdip in the extracellular media after
recombinant expression of an insulin precursor (Roth et al., 2018). One explanation is that these
proteins, which are intended to remain in the ER, might likely be sent out of the ER due to
excessive ER stress caused by recombinant protein occupancy expression (Liu et al., 2005;
Guerfal et al., 2010). A second possibility is that Kar2/Bip could be bound to the aberrant
proteins as they traverse through the secretory pathway (Roth et al., 2018). Within the bgs13
cells, higher amounts of Pdip could possibly be packaged into secretory vesicles during the
secretion process and being sent out into the media along with other proteins intended for
secretion (Huang et al., 2011). In addition to the UPR-associated proteins, many heat shock
response chaperone proteins involved in misfolding/aggregation were identified. Detection of
heat shock proteins and chaperones in higher abundance in the bgs13 ECM, such as STI1p and
Hsp42p, suggests the increased presence of misfolded proteins being produced in the cells. It is
important to note that the identification of these proteins occurred in both strains, but their
relative abundance differs.
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Overall, the bgs13 strain released the majority of the identified proteins in higher
abundance than the strain with the wild-type Bgs13 protein. This included EGFP and MBP
reporter proteins, known secreted proteins, cell-wall associated proteins, UPR-associated
proteins, and even an array of heat shock proteins. To address whether these differences in the
protein populations of the post-induction ECM were due to a change in cell wall integrity that
leads to a release of more protein, we next aimed to perform a deeper analysis of the P. pastoris
cell wall of these two strains and its relationship to the ECM protein population.
Cell Wall Protein Extraction: Silver Stain Results
Initial observations of cell wall integrity being compromised in the bgs13 strain (Larsen
et al., 2013) led to the hypothesis that the pREMI-derived mutation in the BGS13 gene caused a
change in the cell wall architecture, leading to the supersecretion phenotype. In addition,
transmission electron microscopy (TEM) of the bgs13 cells revealed a thicker cell wall compared
to the wild-type cells (Naranjo et al., 2019). Thus, further analysis of the cell wall and its
structure were needed. DTT-extracted cell-wall associated proteins from both the wild-type and
bgs13 cells were compared and analyzed by SDS-PAGE to provide insight into any structural
changes of the cell wall that would lead to liberation of proteins. In order to extract more details
about these differences, label-free mass spectrometry analysis was performed on these protein
populations.
Cell Wall Protein Extraction: MS/MS Analysis
From the cell walls of cells separated from the extracellular supernatant after methanolinduced recombinant expression, label-free quantitative mass spectrometry identified 358
proteins present in both the bgs13 and wild-type extractions Like the protein populations of the
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extracellular media, most of the proteins were found to be more abundant in the bgs13 cells.
This could be related to the thicker cell walls of the bgs13 cells, which leads to higher retention
of proteins within the structure. Again, this number is mainly comprised of proteins with an
intracellular subcellular location and/or origin. Unlike the ECM protein population, this may not
be due to a cell lysis-related cause because the cells were washed prior to the DTT extraction.
However, cells may have lysed during the DTT extraction process. Proteins with an intracellular
origin that were found to be extracted from the cell wall include the UPR-associated Kar2/Bip
and Pdip. Both were found in higher abundance in the bgs13 cell wall with abundance ratios of
2.292 and 1.700, respectively. Their identification here is most likely related to their presence in
the media since they must pass through the cell wall prior to secretion out of the cell. Alcohol
oxidase was another intracellular protein that was extracted from both strains and had a higher
abundance in the bgs13 extraction (with an abundance ratio of 4.510). This high amount of
alcohol oxidase suggests possible cell lysis from the DTT extraction. A variety of vacuolar
proteases that contain SP sequences, indicating they were destined for the secretory pathway,
were also found. For recombinant protein expression in this strain, the presence of proteases in
the cell wall and their possible effects on proteins intended for secretion begs for further
consideration.
Previously characterized cell-wall associated proteins that were identified showed no
general trend of down-regulation nor up-regulation regarding their relative abundance between
bgs13 and wild-type cells (Table 4); while some were found to be less abundant in the bgs13
extraction, others were found higher in abundance, such as two 1,3-ß-glucanosyltransferase
isoforms, one encoded by GAS1 (and the other, encoded by ATY40_BA7501626), was also
found in the ECM of both strains with an abundance ratio of 4.268). These enzymes, specifically
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Gas1p, are involved in cell wall assembly; as shown in S. cerevisiae, they essentially elongate β‐
(1,3)‐glucan chains for assembly and morphogenesis of the cell wall (Ragni et al., 2007).
Interestingly, most of the proteins involved in cell wall assembly or biosynthesis were found to
be lower in abundance in the bgs13 cells than in the wild-type. The reason for this is unclear. In
S. cerevisiae, it has been suggested that the PKC1 kinase cascade negatively regulates some
enzymes involved in the biosynthesis and assembly of the cell wall, including the gene product
of BGL2 (Shimizu et al., 1994). It is possible that a similar scenario is occurring in the bgs13
strain of P. pastoris; the hybrid Remi-bgs13p may be enhancing this regulation of cell wallassociated proteins. This can be related to the difference in localization of the Remi-bgs13p, the
loss of the native N-terminal domains, or due to another unknown effect of the mutation in the
BGS13 gene. Nonetheless, the higher abundance of the extracted proteins in the bgs13 strain
alluded to structural differences in the cell wall. We aimed to look at another facet of the cell
wall architecture: the cell wall porosity.
Cell Wall Porosity
An initial hypothesis to explain the increase in the number of proteins exported to the
extracellular media is that the cell wall of the bgs13 cells is more porous (i.e. permeable) than
that of the wild-type strain. Therefore, we performed a porosity assay on wild-type and bgs13
strains expressing the SLPI-myc-6xHis report protein under the AOX1 promoter. Surprisingly,
the polycationic assay revealed that the bgs13 cell walls were less porous than the wild-type cell
walls. It is possible that this is related to the thicker cell wall of the bgs13 strain (Naranjo et al.,
2019) a thicker cell wall contains more cell wall constituents and possibly more proteins, leading
to a lower porosity that would decrease the ingress of the polycationic polymers through the cell.
The bgs13 strain has shown increased sensitivity to Congo red and Calcofluor white, two drugs
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that affect cell assembly via binding to chitin (Ram and Kliss, 2006; Naranjo et al., 2019) the
thicker cell wall may be related to an elevated composition of chitin in the cell wall. However,
further structural characterization of the bgs13 cell wall constituents is needed to illuminate this
aspect of its cell wall architecture. The assay suggested that a change in cell wall porosity is
likely not the cause of the increased export of proteins into the extracellular media of the bgs13
strain. However, the possibility that the change in porosity arose as an effect of the bgs13
mutation should still be taken into consideration.
Unfolded Protein Response: Intracellular PDI Expression
In order to develop a comprehensive understanding of the mechanisms underlying the
observed enhanced secretion of the bgs13 strain, we explored what effects were occurring on the
UPR after the induction of recombinant protein expression. Because Pdip and Kar2/Bip were
found to be higher in abundance in the bgs13 cell wall and ECM than the wild-type, intracellular
levels of Pdip were analyzed to determine ER chaperone’s abundance along its route through the
secretory pathway of the mutant strain: from the ER to the ECM. Like past studies, intracellular
Pdip was found in the insoluble membrane-associated fraction and not the soluble cytoplasmic
fraction (Damasceno et al., 2007). The extraction of Pdip was performed on strains that
recombinantly expressed the SLPI protein, whose native conformation contains eight disulfide
bonds. The western analysis of the Pdip-containing insoluble membrane-associated fractions
detected approximately equal amounts of the protein between the bgs13 and wild-type strains.
Taken together, the results that demonstrated higher Pdip levels in the cell wall and ECM, but
similar levels inside the cell, suggested that the bgs13 cells cannot retain the chaperone within
the ER. Thus, the overexpressed Pdip gets shuttled through the secretory pathway to the cell
wall and ECM. Since past research has identified UPR-associated chaperones traversing through
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the secretory pathway with proteins intended for secretion (Roth et al., 2018), it is unclear
whether the increased presence of the ER-resident chaperones in the bgs13 ECM and cell wall
indicates that they are a hindrance or benefit to the secretion of recombinant proteins. Thus,
further analysis and characterization of the folding capabilities of the bgs13 must be performed.
The link between quality control mechanisms of the UPR and cell wall integrity has been
established in S. cerevisiae (Scrimale et al., 2009). Therefore, a similar situation could be taking
place in the P. pastoris strains, leading to two possible models. Both models rely on the premise
that P. pastoris only secrete proteins that are properly folded. In the first model, if the proteins,
found in the ECM and cell wall extract of the bgs13 strain compared to the wild-type, are in
higher abundance but irregularly folded, it would suggest a type of deactivation of the UPR. In
this case, misfolded and/or incorrectly modified proteins would circumvent targeted degradation
by the ER-associated degradation (ERAD) pathway or by the vacuole and instead enter the cell
wall or ECM. In our second model, the bgs13 strain provides a stimulation of one aspect of the
UPR, which would trigger an increase in folding with high fidelity that leads to a rise in the
secretion of properly folded proteins. In our lab, structural characterization was performed on
SLPI expressed under the effects of Pdip overexpression in the past (Li et al., 2010), so a similar
analysis would prove useful to study the effect of the bgs13 mutation on the expression of SLPI
and its tertiary structure. To investigate this, future work would include structural
characterization of the recombinant SLPI protein, produced in strains containing either the wildtype Bgs13 or Remi-bgs13 peptide, to detect any differences in the formation of the
intramolecular disulfide bridges. Structural characterization can be performed via methods such
as mass spectrometry and x-ray crystallography. Any elucidated differences in conformation
would provide insight into the folding capabilities and UPR response of the bgs13 strain
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compared to wild-type. Regarding cell wall integrity and structure, another protein of interest for
structural characterization would include the 1,3-ß-glucanosyltransferases encoded by GAS1
because it has shown to have seven disulfide bridges, many of which are necessary for proper
folding and substrate binding (Popolo et al., 2008).
Conclusion
The Remi-bgs13 peptide derived from the pREMI insertion into the BGS13 locus led to a
increased secretion of reporter proteins, indicating its potential to be a Pichia pastoris strain
capable of universal enhanced secretion (Levin et al., 2013) of recombinant proteins.
Additionally, the mutant bgs13 allele led to an aberrant cell wall, a change in protein sorting of
recombinant reporter proteins, and a different localization of the Remi-bgs13 peptide compared
to the native wild-type protein (Levin et al., 2013; Moua et al., 2016; Naranjo et al., 2019).
Analysis of the extracellular media and cell wall revealed an increased abundance of proteins
from bgs13, many of which help elucidate the inner mechanisms of the bgs13 strain involving a
change in cell wall integrity and even the UPR response. Interestingly, although the bgs13 cells
produced more extractable proteins from their cell wall compared to the wild-type cells, they
have a lower cell wall porosity. Thus, the increased export of proteins into the ECM is likely not
due to a weaker cell wall.
Since UPR-associated proteins Kar2/Bip and protein disulfide isomerase were identified
in both the ECM and cell wall in higher abundance from bgs13, the UPR response post-induction
of recombinant expression was also examined. Although intracellular Pdip levels were found to
be comparable between bgs13 and its wild-type parent strain, higher abundance in the media and
cell wall suggests that the ER-resident chaperones overwhelmed the capacity of the ER and were
exported into the cell wall and subsequent extracellular media. This result points to the
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possibility of an unorthodox mode of protein sorting in the bgs13 strain (Moua et al., 2013) that
causes enhanced release of proteins and a resultant aberrant cell wall.
Although mass spectrometry data revealed distinctive UPR involvement in methanolinduced recombinant expression within the bgs13 strain, it is still unclear whether a change in the
UPR response is leading to enhanced secretion of proteins with a proper conformation due to
enhanced folding capabilities or increased release of misfolded proteins due to improper quality
control and degradation. Thus, future experiments should aim to structurally characterize
recombinantly expressed SLPI protein in order to reveal any possible differences in folding and
disulfide bond formation. As another means of investigating the role of the Bgs13 peptide in the
cell wall integrity pathway, we aim to identify any changes in activation of the downstream MAP
kinase pathway that differ between the bgs13 mutant and its wild-type parent. Discerning this
aspect of the bgs13 strain will reveal the true nature of its capabilities for enhanced secretion, but
most importantly, it will provide insight into the secretory mechanisms of P. pastoris which can
be utilized to optimize recombinant protein expression in this valuable host organism.
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